Limited Generalizability of a Retrospective Chart Review Comparing 3 Recombinant FVIII Products for Hemophilia A Prophylaxis.
Where this comes from
- Record sourced from PubMed, PMID 32857650.
- Also identified by DOI 10.18553/jmcp.2020.26.9.1177 and PMC identifier 10391026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
No funding supported the writing of this letter. Preblick, Ali, and DasMahapatra are employees and shareholders of Sanofi Genzyme. Gray is a postdoctoral fellow at Sanofi Genzyme and Rutgers University.
Medical subject headings
- Hemophilia A